CEU San Pablo University will host in the first quarter of 2022 a new postdoctoral researcher with a Marie Sklodowska-Curie Individual Fellowship (MSCA-IF) within the framework of the Horizon 2020 European Research and Innovation program. Doctor Mateusz Dasko will join the project "Design, synthesis and biological evaluation of PROteolysis-TArgeting Chimeric (PROTAC) molecules as anticancer agents, PROTACs - Project ID: 101031883", whose purpose is to develop drugs with antitumor activity through protein degradation. The research will be led by the Professor of the Faculty of Pharmacy, Beatriz de Pascual-Teresa and the assistant Irene Ortín Remón.

The interdisciplinary project will cover different stages of drug development such as design, synthesis and biological evaluation. In addition, Mateusz will  spend a period doing research at the Università degli Studi di Torino (UniTO) in collaboration with Dr. Giulia Caron for the study of  physicochemical properties in the search for the candidate drug and will also spend time researching  at the company CsFlowChem in collaboration with the Dr. Jaime Blanco, for the synthesis scaling process. At the same time Mateusz will be involved in educational and informative activities developed at CEU San Pablo University.

Mateusz Dasko new MSCA-IF at USP-CEU

Mateusz Dasko has a degree in Biotechnological Engineering from Gdansk University of Technology (Poland), where he continued his Master's studies in Biotechnological Sciences and later obtained  his Doctorate with the work entitled “Design, synthesis and biological evaluation of new inhibitors of steroid sulphatase (STS) based on sulphamate analogs containing CF bonds”. Highlighting the awards received in both Master and Doctorate studies. As a researcher he has collaborated with companies such as Polpharma S.A. and Pfizer and he has completed a pre doctoral stay in the group of Prof. Ana Mª Ramos and Beatriz de Pascual-Teresa. He is currently an assistant professor at the Faculty of Chemistry at the Gdansk University of Technology in Poland.

Dr. Mateusz Dasko is the second researcher to join the Competitive Group  PROLIGAR with an MSCA-IF, after Dr. Loganathan Rangasamy (2018-2020). This Group is the first at CEU San Pablo University to achieve two projects in the H2020 Framework Program.